Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats-Reference-Cited by-同舟云学术

Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats

Published:2013-08-07 Issue:4 Volume:58 Page:1424-1435
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Rosado Eugenio¹,Rodríguez-Vilarrupla Aina¹,Gracia-Sancho Jorge¹,Tripathi Dinesh¹,García-Calderó Héctor¹,Bosch Jaume¹,García-Pagán Juan Carlos¹

Affiliation:

1. Hepatic Hemodynamic Laboratory, Liver Unit, IMDIM, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Ciberehd; University of Barcelona; Barcelona; Spain

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26520/fullpdf

Reference42 articles.

1. Complications of cirrhosis. I. Portal hypertension;Bosch;J Hepatol,2000

2. Portal hypertension: from bedside to bench;Groszmann;J Clin Gastroenterol,2005

3. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers;Graupera;Hepatology,2003

4. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers;Graupera;J Hepatol,2003

5. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough;Wiest;Hepatology,2002

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology and therapeutic options for cirrhotic portal hypertension;The Lancet Gastroenterology & Hepatology;2024-07

2. Targeting HSP47 for cancer treatment;Anti-Cancer Drugs;2024-04-29

3. Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension;Hepatobiliary & Pancreatic Diseases International;2024-02

4. Role of liver sinusoidal endothelial cells in the diagnosis and treatment of liver diseases;Sinusoidal Cells in Liver Diseases;2024

5. Cholestatic diseases;Sinusoidal Cells in Liver Diseases;2024